Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Imara
Biotech
Enliven, Imara to merge into 1 oncology biotech
Enliven Therapeutics and Imara are set to merge by Q1 of 2023 in tandem with a Roche-backed $165 million fundraise for the new combo compnany.
Gabrielle Masson
Oct 14, 2022 11:30am
Imara layoffs leave only 6 full-time employees standing
Apr 19, 2022 10:36am
Imara flunks a pair of phase 2bs, wiping out clinical pipeline
Apr 5, 2022 8:35am
JPM: Imara CEO on fighting sickle cell disease during COVID-19
Jan 13, 2021 10:25am
Zentalis pulls off speedy $165M IPO amid pandemic uncertainty
Apr 3, 2020 10:10am
Crossover round, check. New team of execs, check. Now, an IPO
Feb 18, 2020 9:05am
